Cargando…
Multi-kinase targeted therapy as a promising treatment strategy for ovarian tumors expressing sfRon receptor
The sfRon kinase is an important therapeutic target in ovarian cancer that contributes to prominent tumor growth and disease progression. We reasoned that a multi-kinase inhibition of sfRon pathway might be an effective strategy to achieve a sustained anti-tumor response, while simultaneously preven...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805538/ https://www.ncbi.nlm.nih.gov/pubmed/33488949 http://dx.doi.org/10.18632/genesandcancer.205 |